Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients

Ken Shirabe, Masanori Yoshimatsu, Takashi Motomura, Kazuki Takeishi, Takeo Toshima, Jun Muto, Rumi Matono, Akinobu Taketomi, Hideaki Uchiyama, Yoshihiko Maehara

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The aim of this study was to investigate the effects of preoperative oral supplementation with branched-chain amino acids (BCAAs) on postoperative bacteremia after living donor liver transplantation (LDLT) for chronic liver failure. Two hundred thirty-six patients who underwent adult-to-adult LDLT were evaluated in this retrospective study. The patients were divided into 2 groups: those who received oral supplementation with BCAAs before transplantation (the BCAA group; n = 129) and those who did not (the non-BCAA group; n = 107). Before the LDLT indication was determined, BCAA supplementation was prescribed by a hepatologist to preserve hepatic reserves. The clinical characteristics and the incidence of bacteremia were compared between the 2 groups. As for clinical characteristics, the Child-Pugh scores (P = 0.0003) and the Model for End-Stage Liver Disease scores (P = 0.0008) were significantly higher in the BCAA group versus the non-BCAA group. The incidence of bacteremia for Child-Pugh class C patients was significantly lower in the BCAA group (6/90 or 6.7%) versus the non-BCAA group (11/50 or 22.0%, P = 0.0132). In a multivariate analysis, non-BCAA supplementation was an independent risk factor for bacteremia. In conclusion, preoperative BCAA supplementation might reduce the incidence of bacteremia after LDLT. Nevertheless, this is a preliminary report, and further studies, such as randomized, prospective studies, are necessary to clarify the beneficial effects of BCAA supplementation on postoperative bacteremia after liver transplantation.

Original languageEnglish
Pages (from-to)1073-1080
Number of pages8
JournalLiver Transplantation
Volume17
Issue number9
DOIs
Publication statusPublished - Sep 1 2011

Fingerprint

Branched Chain Amino Acids
Living Donors
Bacteremia
Liver Transplantation
Liver
Amino Acids
End Stage Liver Disease
Incidence
Transplant Recipients
Multivariate Analysis
Retrospective Studies
Transplantation
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Surgery
  • Hepatology
  • Transplantation

Cite this

Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. / Shirabe, Ken; Yoshimatsu, Masanori; Motomura, Takashi; Takeishi, Kazuki; Toshima, Takeo; Muto, Jun; Matono, Rumi; Taketomi, Akinobu; Uchiyama, Hideaki; Maehara, Yoshihiko.

In: Liver Transplantation, Vol. 17, No. 9, 01.09.2011, p. 1073-1080.

Research output: Contribution to journalArticle

Shirabe, K, Yoshimatsu, M, Motomura, T, Takeishi, K, Toshima, T, Muto, J, Matono, R, Taketomi, A, Uchiyama, H & Maehara, Y 2011, 'Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients', Liver Transplantation, vol. 17, no. 9, pp. 1073-1080. https://doi.org/10.1002/lt.22324
Shirabe, Ken ; Yoshimatsu, Masanori ; Motomura, Takashi ; Takeishi, Kazuki ; Toshima, Takeo ; Muto, Jun ; Matono, Rumi ; Taketomi, Akinobu ; Uchiyama, Hideaki ; Maehara, Yoshihiko. / Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. In: Liver Transplantation. 2011 ; Vol. 17, No. 9. pp. 1073-1080.
@article{017b2775b4264e3f925ed51949b28593,
title = "Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients",
abstract = "The aim of this study was to investigate the effects of preoperative oral supplementation with branched-chain amino acids (BCAAs) on postoperative bacteremia after living donor liver transplantation (LDLT) for chronic liver failure. Two hundred thirty-six patients who underwent adult-to-adult LDLT were evaluated in this retrospective study. The patients were divided into 2 groups: those who received oral supplementation with BCAAs before transplantation (the BCAA group; n = 129) and those who did not (the non-BCAA group; n = 107). Before the LDLT indication was determined, BCAA supplementation was prescribed by a hepatologist to preserve hepatic reserves. The clinical characteristics and the incidence of bacteremia were compared between the 2 groups. As for clinical characteristics, the Child-Pugh scores (P = 0.0003) and the Model for End-Stage Liver Disease scores (P = 0.0008) were significantly higher in the BCAA group versus the non-BCAA group. The incidence of bacteremia for Child-Pugh class C patients was significantly lower in the BCAA group (6/90 or 6.7{\%}) versus the non-BCAA group (11/50 or 22.0{\%}, P = 0.0132). In a multivariate analysis, non-BCAA supplementation was an independent risk factor for bacteremia. In conclusion, preoperative BCAA supplementation might reduce the incidence of bacteremia after LDLT. Nevertheless, this is a preliminary report, and further studies, such as randomized, prospective studies, are necessary to clarify the beneficial effects of BCAA supplementation on postoperative bacteremia after liver transplantation.",
author = "Ken Shirabe and Masanori Yoshimatsu and Takashi Motomura and Kazuki Takeishi and Takeo Toshima and Jun Muto and Rumi Matono and Akinobu Taketomi and Hideaki Uchiyama and Yoshihiko Maehara",
year = "2011",
month = "9",
day = "1",
doi = "10.1002/lt.22324",
language = "English",
volume = "17",
pages = "1073--1080",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "9",

}

TY - JOUR

T1 - Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients

AU - Shirabe, Ken

AU - Yoshimatsu, Masanori

AU - Motomura, Takashi

AU - Takeishi, Kazuki

AU - Toshima, Takeo

AU - Muto, Jun

AU - Matono, Rumi

AU - Taketomi, Akinobu

AU - Uchiyama, Hideaki

AU - Maehara, Yoshihiko

PY - 2011/9/1

Y1 - 2011/9/1

N2 - The aim of this study was to investigate the effects of preoperative oral supplementation with branched-chain amino acids (BCAAs) on postoperative bacteremia after living donor liver transplantation (LDLT) for chronic liver failure. Two hundred thirty-six patients who underwent adult-to-adult LDLT were evaluated in this retrospective study. The patients were divided into 2 groups: those who received oral supplementation with BCAAs before transplantation (the BCAA group; n = 129) and those who did not (the non-BCAA group; n = 107). Before the LDLT indication was determined, BCAA supplementation was prescribed by a hepatologist to preserve hepatic reserves. The clinical characteristics and the incidence of bacteremia were compared between the 2 groups. As for clinical characteristics, the Child-Pugh scores (P = 0.0003) and the Model for End-Stage Liver Disease scores (P = 0.0008) were significantly higher in the BCAA group versus the non-BCAA group. The incidence of bacteremia for Child-Pugh class C patients was significantly lower in the BCAA group (6/90 or 6.7%) versus the non-BCAA group (11/50 or 22.0%, P = 0.0132). In a multivariate analysis, non-BCAA supplementation was an independent risk factor for bacteremia. In conclusion, preoperative BCAA supplementation might reduce the incidence of bacteremia after LDLT. Nevertheless, this is a preliminary report, and further studies, such as randomized, prospective studies, are necessary to clarify the beneficial effects of BCAA supplementation on postoperative bacteremia after liver transplantation.

AB - The aim of this study was to investigate the effects of preoperative oral supplementation with branched-chain amino acids (BCAAs) on postoperative bacteremia after living donor liver transplantation (LDLT) for chronic liver failure. Two hundred thirty-six patients who underwent adult-to-adult LDLT were evaluated in this retrospective study. The patients were divided into 2 groups: those who received oral supplementation with BCAAs before transplantation (the BCAA group; n = 129) and those who did not (the non-BCAA group; n = 107). Before the LDLT indication was determined, BCAA supplementation was prescribed by a hepatologist to preserve hepatic reserves. The clinical characteristics and the incidence of bacteremia were compared between the 2 groups. As for clinical characteristics, the Child-Pugh scores (P = 0.0003) and the Model for End-Stage Liver Disease scores (P = 0.0008) were significantly higher in the BCAA group versus the non-BCAA group. The incidence of bacteremia for Child-Pugh class C patients was significantly lower in the BCAA group (6/90 or 6.7%) versus the non-BCAA group (11/50 or 22.0%, P = 0.0132). In a multivariate analysis, non-BCAA supplementation was an independent risk factor for bacteremia. In conclusion, preoperative BCAA supplementation might reduce the incidence of bacteremia after LDLT. Nevertheless, this is a preliminary report, and further studies, such as randomized, prospective studies, are necessary to clarify the beneficial effects of BCAA supplementation on postoperative bacteremia after liver transplantation.

UR - http://www.scopus.com/inward/record.url?scp=80051965782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051965782&partnerID=8YFLogxK

U2 - 10.1002/lt.22324

DO - 10.1002/lt.22324

M3 - Article

C2 - 21542128

AN - SCOPUS:80051965782

VL - 17

SP - 1073

EP - 1080

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 9

ER -